11 May 2015
(Oxford, UK, 11 May 2015) Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer, viral infections and autoimmune diseases, today announced that Eva-Lotta Allan, Chief Business Officer, will participate in the Citi European Healthcare Conference in London on 15th June 2015.
Additionally, Eliot Forster, Chief Executive Officer, will participate in a panel discussion at the BioTrinity Conference in London on 13th May 2015.
Please click on the link below to download the full Press Release:
Immunocore to attend Citi European Healthcare Conference 2015 and BioTrinity 2015
